BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14991022)

  • 1. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines.
    Wang C; Ge Q; Ting D; Nguyen D; Shen HR; Chen J; Eisen HN; Heller J; Langer R; Putnam D
    Nat Mater; 2004 Mar; 3(3):190-6. PubMed ID: 14991022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing is everything.
    Pack DW
    Nat Mater; 2004 Mar; 3(3):133-4. PubMed ID: 14991008
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles for the delivery of DNA vaccines.
    O'Hagan DT; Singh M; Ulmer JB
    Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-site DNA vaccination enhances immune responses in mice.
    Gardiner DF; Huang Y; Basu S; Leung L; Song Y; Chen Z; Ho DD
    Vaccine; 2006 Jan; 24(3):287-92. PubMed ID: 16137804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.
    Minigo G; Scholzen A; Tang CK; Hanley JC; Kalkanidis M; Pietersz GA; Apostolopoulos V; Plebanski M
    Vaccine; 2007 Jan; 25(7):1316-27. PubMed ID: 17052812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.
    Heit A; Schmitz F; Haas T; Busch DH; Wagner H
    Eur J Immunol; 2007 Aug; 37(8):2063-74. PubMed ID: 17628858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
    Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice.
    Cai H; Hu XD; Yu DH; Li SX; Tian X; Zhu YX
    Vaccine; 2005 Jul; 23(32):4167-74. PubMed ID: 15908060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
    Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
    Chan T; Sami A; El-Gayed A; Guo X; Xiang J
    Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF; Hough J; Henderson D; Escher A
    Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasmid DNA encoding the porcine granulocyte-macrophage colony-stimulating factor on antigen-presenting cells in pigs.
    Melkebeek V; Van den Broeck W; Verdonck F; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):354-60. PubMed ID: 18762341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
    Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
    Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.